7.1 C
New York
Wednesday, March 22, 2023

Are Things Looking Up For Dynavax Technologies Corporation (NASDAQ: DVAX)?

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Dynavax Technologies Corporation (DVAX) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.21, or -2.15%, to $9.57. The Dynavax Technologies Corporation has recorded 39,677 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Dynavax to Present at the Cowen 43rd Annual Health Care Conference.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Stocks Info

The company is listed on the NASDAQ and operates within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $9.78 and fluctuated between $9.81 as its day high and $9.51 as its day low. The current market capitalization of Dynavax Technologies Corporation is $1.27B. A total of 1.32 million shares were traded on the day, compared to an average of 1.51M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, DVAX has seen 17 BUY and 17 SELL insider trades, representing the acquisition of 143,267 and the disposition of 80,071 shares. Over the last 12 months, there were 30 BUYs and 29 SELLs from insiders. Insiders purchased 266,306 shares during that period but sold 4,746,406.

In the most recent transaction, Burgess Justin sold 22,371 shares of DVAX for 10.38 per share on Feb 27. After the transaction, the Chief Accounting Officer now owns 0 company shares. In a previous transaction on Dec 06, Hack Andrew A. F. sold 1,500,000 shares at 11.60 per share. DVAX shares that Director owns now total 3,915,000.

Among the insiders who sold shares, Novack David F disposed of 52,204 shares on Nov 08 at a per-share price of $12.47. This resulted in the President & COO holding 2,066 shares of DVAX after the transaction. In another insider transaction, Hack Andrew A. F. sold 3,000,000 shares at $14.68 per share on Aug 15. Company shares held by the Director now total 5,415,000.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for DVAX in the last 3 months, the mean price target is $23.17 with high estimates of $27.00 and low estimates of $18.00. In terms of 52-week highs and lows, DVAX has a high of $17.48 and a low of $7.26.

As of this writing, DVAX has an earnings estimate of $0.43 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.52 per share and a lower estimate of $0.34. The company reported an EPS of $0.87 in the last quarter, which was 295.50% higher than expectations of $0.22.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 6 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DVAX is Overweight with a score of 5.00. A total of 6 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles